Methods and materials for enzymatic synthesis of mogroside compounds

US10738340B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10738340-B2
Application numberUS-201815889743-A
CountryUS
Kind codeB2
Filing dateFeb 6, 2018
Priority dateNov 23, 2011
Publication dateAug 11, 2020
Grant dateAug 11, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and materials for enzymatic synthesis of mogroside compounds described.

First claim

Opening claim text (preview).

The invention claimed is: 1. An in vitro method for transferring a sugar moiety to a mogrol, a glycosylated mogroside compound, or both the mogrol and the glycosylated mogroside compound, comprising contacting the mogrol, the glycosylated mogroside compound, or both the mogrol and the glycosylated mogroside compound with one or more recombinant polypeptides capable of glycosylation at C3′-OH, C24′-OH, C3′-OH and C24′-OH, or C25′-OH of the mogrol, at C3′-OH or C24′-OH of the glycosylated mogroside compound, or both C3′-OH, C24′-OH, C3′-OH and C24′-OH, or C25′-OH of the mogrol and C3′-OH or C24′-OH of the glycosylated mogroside compound, and one or more UDP-sugars, under suitable reaction conditions for the transfer of one or more sugar moieties from the one or more UDP-sugars to the mogrol, the glycosylated mogroside compound, or both the mogrol and the glycosylated mogroside compound; wherein a mogroside compound glycosylated at C3′-OH, a mogroside compound glycosylated at C24′-OH, a mogroside compound glycosylated at C25′-OH, a mogroside compound glycosylated at C3′-OH and C24′-OH, a mogroside compound glycosylated at C3′-OH and tri-glycosylated at C24′ position, an isomer thereof, and/or a mogroside composition thereof is produced upon transfer of the sugar moiety; and wherein the one or more recombinant polypeptides comprise at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NOs. 1-5. 2. The method of claim 1 , wherein: (a) the UDP-sugar is UDP-glucose, and the mogroside compound glycosylated at C3′-OH is produced upon transfer of the glucose moiety to C3′-OH of the mogrol; (b) the UDP-sugar is UDP-glucose, and the mogroside compound glycosylated at C24′-OH is produced upon transfer of the glucose moiety to C24′-OH of the mogrol; (c) the UDP-sugar is UDP-glucose, and the mogroside compound glycosylated at C25′-OH is produced upon transfer of the glucose moiety to C25′-OH of the mogrol; (d) the UDP-sugar is UDP-glucose, and the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety to C3′-OH and C24′-OH of the mogrol; (e) the UDP-sugar is UDP-glucose, and the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety to C3′-OH of the mogroside compound glycosylated at C24′-OH; (f) the UDP-sugar is UDP-glucose, and the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety to C24′-OH of the mogroside compound glycosylated at C3′-OH; and (g) the UDP-sugar is UDP-glucose, and the mogroside compound glycosylated at C3′-OH and tri-glycosylated at C24′ position is produced upon transfer of the glucose moiety to C3′-OH of the mogroside compound tri-glycosylated at C24′ position. 3. The method of claim 1 , wherein: (a) the UDP-sugar is UDP-glucose, the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:2, and the mogroside compound glycosylated at C3′-OH is produced upon transfer of the glucose moiety to C3′-OH of the mogrol; (b) the UDP-sugar is UDP-glucose, the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:1-5, and the mogroside compound glycosylated at C24′-OH is produced upon transfer of the glucose moiety to C24′-OH of the mogrol; (c) the UDP-sugar is UDP-glucose, the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:4, and the mogroside compound glycosylated at C25′-OH is produced upon transfer of the glucose moiety to C25′-OH of the mogrol; (d) the UDP-sugar is UDP-glucose, the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:1-5, and the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety to C3′-OH and C24′-OH of the mogrol; (e) the UDP-sugar is UDP-glucose, the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:1 or 3-5, and the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety to C3′-OH of the mogroside compound glycosylated at C24′-OH; (f) the UDP-sugar is UDP-glucose, the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:2, and the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety to C24′-OH of the mogroside compound glycosylated at C3′-OH; and (g) the UDP-sugar is UDP-glucose, the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:2, and the mogroside compound glycosylated at C3′-OH and tri-glycosylated at C24′ position is produced upon transfer of the glucose moiety to C3′-OH of the mogroside compound tri-glycosylated at C24′ position. 4. The method of claim 1 , wherein: (a) the mogroside compound glycosylated at C3′-OH is produced upon transfer of the glucose moiety of the UDP-glucose to C3′-OH of the mogrol effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:2; (b) the mogroside compound glycosylated at C24′-OH is produced upon transfer of the glucose moiety of the UDP-glucose C24′-OH of the mogrol effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:1-5; (c) the mogroside compound glycosylated at C25′-OH is produced upon transfer of the glucose moiety of the UDP-glucose to C25′-OH of the mogrol effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:4; (d) the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety of the UDP-glucose to C3′-OH and C24′-OH of the mogrol effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:1-5; (e) the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety of the UDP-glucose to C3′-OH of the mogroside compound glycosylated at C24′-OH effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:1 or 3-5; (f) the mogroside compound glycosylated at C3′-OH and C24′-OH is produced upon transfer of the glucose moiety of the UDP-glucose to C24′-OH of the mogroside compound glycosylated at C3′-OH effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:2; and (g) the mogroside compound glycosylated at C3′-OH and tri-glycosylated at C24′ position is produced upon transfer of the glucose moiety of the UDP-glucose to C3′-OH of the mogroside compound tri-glycosylated at C24′ position effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:2. 5. The method of claim 1 , further comprising isolating the mogroside compound glycosylated at C3′-OH, the mogroside compound glycosylated at C24′-OH, the mogroside compound glycosylated at C25′-OH, the mogroside compound glycosylated at C3′-OH and C24′-OH, the mogroside compound glycosylated at C3′-OH and tri-glycosylated at C24′ position, the isomer the

Assignees

Inventors

Classifications

  • C12P19/18Primary

    produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title

  • C12P33/20Primary

    containing heterocyclic rings · CPC title

  • Preparation of steroids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10738340B2 cover?
Methods and materials for enzymatic synthesis of mogroside compounds described.
Who is the assignee on this patent?
Evolva Sa
What technology area does this patent fall under?
Primary CPC classification C12P19/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).